These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521 [TBL] [Abstract][Full Text] [Related]
43. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines]. Lu Y; Liao QP; Chen CL; Yu L Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617 [TBL] [Abstract][Full Text] [Related]
44. Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells. Stöhr O; Hahn J; Moll L; Leeser U; Freude S; Bernard C; Schilbach K; Markl A; Udelhoven M; Krone W; Schubert M Biochim Biophys Acta; 2011 May; 1812(5):573-80. PubMed ID: 21354306 [TBL] [Abstract][Full Text] [Related]
45. Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture. Haslam SZ; Drolet A; Smith K; Tan M; Aupperlee M Endocrinology; 2008 May; 149(5):2098-107. PubMed ID: 18218689 [TBL] [Abstract][Full Text] [Related]
46. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro. Mirdamadi Y; Thielitz A; Wiede A; Goihl A; Papakonstantinou E; Hartig R; Zouboulis CC; Reinhold D; Simeoni L; Bommhardt U; Quist S; Gollnick H Mol Cell Endocrinol; 2015 Nov; 415():32-44. PubMed ID: 26257240 [TBL] [Abstract][Full Text] [Related]
47. LRP16 gene protects mouse insulinoma MIN6 cells against fatty acid-induced apoptosis through Akt/FoxO1 signaling. Li XJ; Guo QH; Wang X; Xue B; Sun LQ; Meng QT; Lu JM; Mu YM Chin Med J (Engl); 2012 May; 125(10):1695-702. PubMed ID: 22800886 [TBL] [Abstract][Full Text] [Related]
48. Luteolytic effect of the antiprogestin and antiglucocorticoid agent RU486 in rats. Arakawa S; Kambegawa A; Okinaga S; Arai K J Steroid Biochem; 1990 Aug; 36(5):479-83. PubMed ID: 2214764 [TBL] [Abstract][Full Text] [Related]
49. FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells. Ju Y; Xu T; Zhang H; Yu A Int J Oncol; 2014 Apr; 44(4):1284-92. PubMed ID: 24452601 [TBL] [Abstract][Full Text] [Related]
50. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Faivre EJ; Daniel AR; Hillard CJ; Lange CA Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149 [TBL] [Abstract][Full Text] [Related]
51. Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism. Zhang L; Feng Q; Wang Z; Liu P; Cui S Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262976 [TBL] [Abstract][Full Text] [Related]
52. Regulation of FOXO1 by TAK1-Nemo-like kinase pathway. Kim S; Kim Y; Lee J; Chung J J Biol Chem; 2010 Mar; 285(11):8122-9. PubMed ID: 20061393 [TBL] [Abstract][Full Text] [Related]
53. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase. Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334 [TBL] [Abstract][Full Text] [Related]
54. TRIM9 overexpression promotes uterine leiomyoma cell proliferation and inhibits cell apoptosis via NF-κB signaling pathway. Yang F; Liu H; Yu Y; Xu L Life Sci; 2020 Sep; 257():118101. PubMed ID: 32679146 [TBL] [Abstract][Full Text] [Related]
55. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells. Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262 [TBL] [Abstract][Full Text] [Related]
56. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins. Terakawa N; Shimizu I; Tanizawa O; Matsumoto K J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133 [TBL] [Abstract][Full Text] [Related]
57. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells. Fang D; Huang Z; Guan H; Liu J; Yao B; Xiao H; Li Y Mol Med Rep; 2012 Jan; 5(1):233-8. PubMed ID: 21964769 [TBL] [Abstract][Full Text] [Related]
58. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell. Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820 [TBL] [Abstract][Full Text] [Related]
59. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. Sasaki H; Ohara N; Xu Q; Wang J; DeManno DA; Chwalisz K; Yoshida S; Maruo T J Clin Endocrinol Metab; 2007 Feb; 92(2):616-23. PubMed ID: 17105846 [TBL] [Abstract][Full Text] [Related]
60. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2. Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]